Wedbush Securities’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-11,759
| Closed | -$44K | – | 1263 |
|
|
2024
Q1 | $44K | Sell |
11,759
-3,058
| -21% | -$11.4K | ﹤0.01% | 1212 |
|
|
2023
Q4 | $145K | Sell |
14,817
-1,139
| -7% | -$11.1K | 0.01% | 1006 |
|
|
2023
Q3 | $133K | Sell |
15,956
-358
| -2% | -$2.98K | 0.01% | 972 |
|
|
2023
Q2 | $217K | Sell |
16,314
-72
| -0.4% | -$958 | 0.01% | 897 |
|
|
2023
Q1 | $190K | Buy |
16,386
+5,339
| +48% | +$61.9K | 0.01% | 953 |
|
|
2022
Q4 | $90K | Sell |
11,047
-102
| -0.9% | -$831 | ﹤0.01% | 993 |
|
|
2022
Q3 | $65K | Sell |
11,149
-1,536
| -12% | -$8.96K | ﹤0.01% | 998 |
|
|
2022
Q2 | $56K | Sell |
12,685
-6,045
| -32% | -$26.7K | ﹤0.01% | 1028 |
|
|
2022
Q1 | $170K | Sell |
18,730
-2,215
| -11% | -$20.1K | 0.01% | 1011 |
|
|
2021
Q4 | $429K | Buy |
20,945
+505
| +2% | +$10.3K | 0.02% | 703 |
|
|
2021
Q3 | $522K | Buy |
20,440
+1,217
| +6% | +$31.1K | 0.02% | 590 |
|
|
2021
Q2 | $672K | Buy |
19,223
+7,648
| +66% | +$267K | 0.03% | 504 |
|
|
2021
Q1 | $386K | Buy |
+11,575
| New | +$386K | 0.02% | 678 |
|